B7-1/CD80 Polyclonal Antibody

Price:
Size:
100 μL
25 μL
- 宿主: Rabbit
- 反应性: Human
- 应用性: IHC
Verified Samples |
Verified Samples in IHC: Human tonsil |
Dilution | IHC 1:100-1:200 |
Clonality | Polyclonal |
Isotype | IgG |
Immunogen | Recombinant Human B7-1/CD80 protein expressed by Mammalian |
Abbre | B7-1/CD80 |
Synonyms | B lymphocyte activation antigen B7, B7-1 antigen, B7-1 antigen, CD28 antigen ligand 1, CD80 antigen, CD80 antigen CD28 antigen ligand 1, CD80 molecule, Costimulatory factor CD80, costimulatory molecule variant IgV-CD80, LAB, CTLA-4 counter-receptor B, T-lymphocyte activation antigen CD, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7, CD80, CD28LGB7-1 antigen, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1, B7-1, BB1 |
Swissprot | |
Cellular Localization | Cell membrane |
Tissue Specificity | Expressed on activated B-cells, macrophages and dendritic cells. |
Concentration | 1 mg/mL |
Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
Buffer | PBS with 0.05% proclin 300, 1% protective protein and 50% glycerol,pH7.4 |
Purification Method | Antigen Affinity Purification |
Research Areas | Immunology, Stem Cells |
Conjugation | Unconjugated |
Background | B7-1 and B7-2, together with their receptors CD28 and CTLA-4, constitute one of the dominant co-stimulatory pathways that regulate T- and B-cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20‑100 fold higher affinity than CD28 and is involved in the down‑regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells, and macrophages. |
Immunohistochemistry of paraffin-embedded Human tonsil using B7-1/CD80 Polyclonal Antibody at dilution of 1:200.